Atom Investors’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
VPM
VCM
AIM
Atom Investors's VCYT Position: Q1 2026 in Review
Atom Investors reduced its Veracyte (VCYT) stake by 11% in Q1 2026, selling an estimated $30.7K and leaving 6,850 shares worth $221K. The position accounts for 0.02% of the portfolio, ranked #598.
Atom Investors first reported a position in VCYT in Q4 2018 and has held it in 16 quarters since. The position peaked at $14.7M in Q1 2019. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.
- Atom Investors held 6,850 shares of Veracyte worth $221K as of Q1 2026.
- Atom Investors sold 829 Veracyte shares in Q1 2026, an estimated $30.7K.
- Veracyte made up 0.02% of Atom Investors's portfolio in Q1 2026, its #598 holding.
- Atom Investors first reported a position in Veracyte in Q4 2018 and has held it in 16 quarters since.
- Atom Investors's Veracyte position peaked at $14.7M in Q1 2019.
- 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.
Based on Atom Investors's 13F filing for Q1 2026, filed 15 May 2026.